Holen Sie sich die Stockscreener-App
11.13
0.36%
-0.04
Handel nachbörslich:
11.13
Schlusskurs vom Vortag:
$11.17
Offen:
$11.2
24-Stunden-Volumen:
601.70K
Relative Volume:
0.86
Marktkapitalisierung:
$1.06B
Einnahmen:
$174.54M
Nettoeinkommen (Verlust:
$6.03M
KGV:
139.12
EPS:
0.08
Netto-Cashflow:
$15.96M
1W Leistung:
+0.27%
1M Leistung:
+6.30%
6M Leistung:
+17.03%
1J Leistung:
+38.61%
1-Tages-Spanne:
$11.11
$11.20
1-Wochen-Bereich:
$11.01
$11.20
52-Wochen-Spanne:
$7.60
$11.38
Enfusion Inc Stock (ENFN) Company Profile
Firmenname
Enfusion Inc
Sektor
Branche
Telefon
(312) 253-9800
Adresse
125 SOUTH CLARK STREET, SUITE 750, CHICAGO
Vergleichen Sie ENFN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ENFN
Enfusion Inc
|
11.13 | 1.06B | 174.54M | 6.03M | 15.96M | 0.08 |
|
CRM
Salesforce Inc
|
343.57 | 329.64B | 37.19B | 5.94B | 11.87B | 6.08 |
|
SAP
Sap Se Adr
|
279.36 | 325.94B | 36.09B | 2.98B | 7.67B | 2.4878 |
|
NOW
Servicenow Inc
|
1,012.75 | 206.16B | 10.46B | 1.34B | 3.35B | 6.43 |
|
INTU
Intuit Inc
|
604.60 | 168.18B | 16.59B | 2.92B | 5.14B | 10.30 |
|
SHOP
Shopify Inc
|
119.18 | 154.26B | 8.21B | 1.38B | 1.43B | 1.07 |
Enfusion Inc Stock (ENFN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-05-10 | Fortgesetzt | Morgan Stanley | Overweight |
| 2024-02-28 | Herabstufung | Goldman | Neutral → Sell |
| 2024-01-30 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2023-11-07 | Eingeleitet | UBS | Neutral |
| 2023-04-03 | Eingeleitet | Piper Sandler | Neutral |
| 2023-03-15 | Eingeleitet | JP Morgan | Neutral |
| 2023-01-04 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-01-03 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-03 | Herabstufung | BofA Securities | Buy → Neutral |
| 2021-11-15 | Eingeleitet | BofA Securities | Buy |
| 2021-11-15 | Eingeleitet | Credit Suisse | Neutral |
| 2021-11-15 | Eingeleitet | Goldman | Neutral |
| 2021-11-15 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-11-15 | Eingeleitet | Piper Sandler | Overweight |
| 2021-11-15 | Eingeleitet | Stifel | Buy |
| 2021-11-15 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Enfusion Inc Aktie (ENFN) Neueste Nachrichten
An Update On The Enfusion Buyout (NYSE:ENFN) - Seeking Alpha
Bronstein, Gewirtz & Grossman, LLC Is Investigating Enfusion, Inc. (ENFN) And Encourages Stockholders to Connect - Markets Insider
Trading (ENFN) With Integrated Risk Controls - Stock Traders Daily
JPMorgan Chase & Co. Grows Holdings in Enfusion, Inc. (NYSE:ENFN) - MarketBeat
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enfusion, Inc. (NYSEENFN), Intra-Cellular Therapies, Inc. (NasdaqITCI), H&E Equipment Services, Inc. (NasdaqHEES), Shutterstock, Inc. (NYSE - GlobeNewswire Inc.
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN, HEES, AMPY, TURN on Behalf of Shareholders - The Eastern Progress Online
Clearwater agrees to buy investment management platform Enfusion for $1.5B - MSN
Enfusion (NYSE:ENFN) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger – CCNE, ITCI, ENFN, AMPY - GlobeNewswire Inc.
Enfusion director Somers sells $17,237 in stock to cover taxes By Investing.com - Investing.com Australia
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Enfusion, Inc. (ENFN) and Encourages Investors to Learn More About the Investigation - Markets Insider
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ENFN and ITCI on Behalf of Shareholders - Longview News-Journal
2025-01-16 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Enfusion, Inc. (ENFN) and Encourages Investors to Learn More About the Investigation | NYSE:ENFN | Press Release - Stockhouse Publishing
Barclays PLC Boosts Stake in Enfusion, Inc. (NYSE:ENFN) - Defense World
Enfusion, Inc. (NYSE:ENFN) Director Deirdre Somers Sells 1,637 Shares - MarketBeat
Enfusion director Somers sells $17,237 in stock to cover taxes - Investing.com India
MS cuts rating on Enfusion stock after Clearwater’s acquisition bid - MSN
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Enfusion, Inc. (ENFN) And Encourages Investors to Reach Out - AccessWire
Analysts Set Enfusion, Inc. (NYSE:ENFN) PT at $10.25 - Defense World
DA Davidson lifts Clearwater stock rating to Buy in light of merger with Enfusion - Investing.com Canada
Clearwater Analytics stock outlook shifts as Enfusion deal sparks mixed market response - Investing.com Canada
2025-01-14 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Enfusion, Inc. (ENFN) And Encourages Investors to Reach Out | NYSE:ENFN | Press Release - Stockhouse Publishing
Enfusion downgraded to Hold from Buy at Stifel - Yahoo Finance
Clearwater Analytics to buy software maker Enfusion for $1.5 billion to drive global expansion - MSN
Clearwater buyout drives Enfusion stock downgrade, says Morgan Stanley By Investing.com - Investing.com Canada
Clearwater buyout drives Enfusion stock downgrade, says Morgan Stanley - Investing.com India
William Blair Downgrades Enfusion (ENFN) - MSN
Clearwater Analytics acquires software maker Enfusion for $1.5 billion to drive global expansion - MSN
Clearwater Analytics to acquire investment management platform Enfusion for $1.5bn - FinTech Futures
Stifel cuts Enfusion stock rating to Hold, lowers price target on acquisition - Investing.com Australia
Enfusion (NYSE:ENFN) Given “Market Perform” Rating at William Blair - Defense World
Clearwater to acquire Enfusion to expand its Investment Management Platform - IBS Intelligence
Clearwater Analytics to acquire Enfusion in $1.5 billion deal - MSN
Clearwater Analytics agrees to by Enfusion for $1.5B - Axios
Clearwater Analytics to build alts platform with Enfusion acquisition - Alternatives Watch
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Enfusion, Inc.ENFN - The Malaysian Reserve
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enfusion, Inc.ENFN - Marketscreener.com
Clearwater Analytics to Buy Investment Management SaaS Platform Enfusion for $1.5 Billion - Finovate
Clearwater to buy software maker Enfusion for $1.5 billion in expansion push - MSN
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Enfusion, Inc. - PrimePublishers.com
Clearwater acquires Enfusion in $1.5B financial software deal - SiliconANGLE News
ENFN Investors Have the Opportunity to Join Investigation of Enfusion, Inc. With the Schall Law Firm - Business Wire
Enfusion (NYSE:ENFN) Given Market Perform Rating at William Blair - MarketBeat
SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates ENFN, ITCI, EDBL on Behalf of Shareholders - Stockhouse Publishing
$HAREHOLDER ALERT: The M&A Class Action Firm Investigates the Me - GuruFocus.com
Finanzdaten der Enfusion Inc-Aktie (ENFN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.34%
2.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):